Hostname: page-component-78c5997874-g7gxr Total loading time: 0 Render date: 2024-11-05T15:24:54.121Z Has data issue: false hasContentIssue false
  • English
  • Français

Catheter-induced acute Blalock–Taussig shunt thrombosis and bailout

Published online by Cambridge University Press:  19 August 2020

Bassel Mohammad Nijres Open the ORCID record for Bassel Mohammad Nijres [Opens in a new window] ,
Paul M. Nelson  and
Joseph J. Vettukattil
Bassel Mohammad Nijres
Affiliation:
Congenital Heart Center, Spectrum Health Helen DeVos Children’s Hospital, Grand Rapids, MI, USA
Paul M. Nelson
Affiliation:
Congenital Heart Center, Spectrum Health Helen DeVos Children’s Hospital, Grand Rapids, MI, USA
Joseph J. Vettukattil*
Affiliation:
Congenital Heart Center, Spectrum Health Helen DeVos Children’s Hospital, Grand Rapids, MI, USA
*
Author for correspondence: Joseph Vettukattil, MD, Spectrum Health Helen DeVos Children’s Hospital, 100 Michigan NE (MC248), Grand Rapids, MI49503, USA. Tel: +1 616 267 0988; Fax: +1 616 267 1408. E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Modified Blalock–Taussig shunt thrombosis is a life-threatening event. We describe an extremely rare catheter-induced shunt thrombosis in an infant with complex CHD and its successful treatment utilising a single low dose of local recombinant tissue plasminogen activator in conjunction with balloon angioplasty.

Keywords

Blalock–Taussig shuntplasminogen activatorrecanalisation
Type
Brief Report
Information
Cardiology in the Young , Volume 30 , Issue 10 , October 2020 , pp. 1512 - 1514
Copyright
© The Author(s), 2020. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Sasikumar, N, Hermuzi, A, Fan, CS, et al. Outcomes of Blalock–Taussig shunts in current era: a single center experience. Congenit Heart Dis 2017; 12: 808–814.CrossRefGoogle ScholarPubMed
Bonnet, M, Petit, J, Lambert, V, et al. Catheter-based interventions for modified Blalock–Taussig shunt obstruction: a 20-year experience. Pediatr Cardiol 2015; 36: 835–841.CrossRefGoogle ScholarPubMed
Patange, A, Blake, J, Gowda, S. Complete Blalock–Taussig shunt obstruction in <24 hours post-operative period in a neonate treated emergently using transcatheter angioplasty and low dose local recombinant TPA. Catheter Cardiovasc Interv 2014; 83: 964–967.CrossRefGoogle Scholar
Moszura, T, Zubrzycka, M, Michalak, KW, et al. Acute and late obstruction of a modified Blalock–Taussig shunt: a two-center experience in different catheter-based methods of treatment. Interact Cardiovasc Thorac Surg 2010; 10: 727–731.CrossRefGoogle ScholarPubMed
Kogon, B, Villari, C, Shah, N, et al. Occlusion of the modified Blalock–Taussig shunt: unique methods of treatment and review of catheter-based intervention. Congenit Heart Dis 2007; 2: 185–190.CrossRefGoogle ScholarPubMed
Gillespie, MJ, Rome, JJ. Transcatheter treatment for systemic-to-pulmonary artery shunt obstruction in infants and children. Catheter Cardiovasc Interv 2008; 71: 928–935.CrossRefGoogle ScholarPubMed
Mohammad Nijres, B, Huntington, JH, Baliulis, G, Vettukattil, JJ. Intracoronary recombinant tissue plasminogen activator in an infant with hypoplastic left heart syndrome and complete left main coronary artery thrombosis. Catheter Cardiovasc Interv 2019; 93: E381–E384.CrossRefGoogle Scholar
Gupta, AA, Leaker, M, Andrew, M, et al. Safety and outcomes of thrombolysis with tissue plasminogen activator for treatment of intravascular thrombosis in children. J Pediatr 2001; 139: 682–688.CrossRefGoogle ScholarPubMed
Newall, F, Browne, M, Savoia, H, Campbell, J, Barnes, C, Monagle, P. Assessing the outcome of systemic tissue plasminogen activator for the management of venous and arterial thrombosis in pediatrics. J Pediatr Hematol Oncol 2007; 29: 269–273.CrossRefGoogle Scholar